Vaccines News
-
Serum Institute acquires Dutch biologics company
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2012
Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine company, has acquired Bilthoven Biologicals of Netherlands. Through the...Read more
-
Mitsubishi to acquire Medicago at $1.16 per share
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles (VL...Read more
-
H7N9 claims more lives in China
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2014
Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new human cases of H7N9 Avian Influenza in four Chinese provinces. The de...Read more
-
Vaccines do not cause autism: Study
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 30 May, 2014
Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childhood vaccination programs. In a study that covered more than 1.25 milli...Read more
-
EU join hands to develop personalized cancer vaccines
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Europe has established Glioma Actively Personalized Vaccine Consortium, (GAPVAC), a project designed to create, manufacture and develop actively personalized vaccines (APVACs) to...Read more
-
Focus on needs of society: Dr Weidong Yin
Vaccines | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012
Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of the Year Award for 2011. Sinovac was established in 2001 with a missio...Read more
-
Panacea gets govt order worth $34 million
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2012
New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order worth $34 million (Rs 187.61 crore) for the supply of 345 million dos...Read more
-
Emergent to market VaxInnate flu vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 31 Dec, 2012
Singapore: Emergent BioSolutions has signed a license agreement with VaxInnate under which Emergent acquired the exclusive right to manufacture and sell VaxInnate's pandemic influenza vacci...Read more
-
WHO: Bird flu is back in China
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013
Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family Planning Commission to World Health Organization (WHO). The cases we...Read more
-
FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-culture-derived vaccine, for individuals 18 years of age and older. Develo...Read more
-
Takeda acquires LigoCyte Pharmaceuticals at $60 mn
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more
-
FDA approves GSK's combo meingitis vaccine
Vaccines | Regulatory | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012
Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine). Men...Read more
-
Biodiem gets US patent allowance for antifungal therapy
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more
-
Arterial Remodeling Technologies receives regulatory approval
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Australian vaccine development company BioDiem Ltd has announced that it has begun research collaboration with France-based VIVALIS, a biopharmaceutical company with expertise in vaccin...Read more
-
'China's H7N9 outbreak an epidemic'
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2014
Singapore: While experts and health ministries in various Chinese provinces have declared the on-going second wave of H7N9 in the country as more destructive than the first one in early 201...Read more
-
Vaccines | News | 0 Comment | 13 Apr, 2017
To quell the rumours around the measles-rubella vaccine, UNICEF has reached out to Islamic civil society organisations, religious leaders and academia to create trust and address myths arou...Read more
-
Globally Zika Virus vaccines market expected to reach $18,697 mn by 2022
Vaccines | News | 0 Comment | 04 Jan, 2017
A new report published by Allied Market Research, titled, “Potential Market for Zika Virus Vaccines: Global Opportunity Analysis and Industry Forecast, 2017–2022”, project...Read more
-
CEPI board meeting with a focus on identifying disease priorities and future strategy
Vaccines | News | 0 Comment | 19 Dec, 2016
The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more
